Dr. Manohar Sai Gowda Memorial Young Investigator Cardiovascular Research Award
Manohar Sai Gowda was born in Nashville, Tennessee. He attended Florida StateUniversity for his undergraduate degree and attended Meharry MedicalCollege in Nashville, Tennessee. He was an Internal Medicine resident and then Cardiovascular fellow at the University of Missouri at Kansas City and St. Luke’s Hospital, Kansas City, Missouri from 1997 until July 2002. He was first and foremost a dedicated and compassionate physician who provided excellent care to his patients.
He was also a remarkably productive clinical researcher while a resident and fellow. Over the course of his training in Kansas City, Dr. Gowda published 9 papers in peer-reviewed medical journals and authored 18 abstracts presented at national meetings. In addition to his clinical skills and contributions to cardiovascular research, he is remembered by his colleagues as brilliant, insightful, and extremely hard-working. He was rarely seen without a smile, and was unfailingly kind and thoughtful to all with whom he interacted. He was a delight to work with, both as a clinician and a researcher.
Thanks to the generous contributions of family and friends of Manohar, we are pleased to announce the Ninth Annual Dr. Manohar Sai Gowda Memorial Young Investigator Cardiovascular Research Award, to be presented at the 2018 Kansas City Heart Rhythm Symposium. This award has been established in appreciation of the late Dr. Gowda’s contributions to cardiovascular research as both an investigator and a mentor to young research scientists.
Nima Ghasemzadeh MD, Emory University, Atlanta, Georgia
Left-Atrial Pulmonary Vein Infarction Leads to Spontaneous Atrial Fibrillation and Regional Action Potential Duration Prolongation
Farshad Forouzandeh MD, PhD, Emory University, Atlanta, Georgia
Metformin Beyond Diabetes: Metformin Attenuates Atherosclerosis and Vascular Action Potential Duration Prolongation
Uma Mahesh Avula MD, University of Michigan, Ann Arbor, Michigan
A Composite Risk Score of Biomarkers of Inflammation, Thrombosis, and Cell Stress Pathways Significantly Predict Risk fo Adverse Cardiovascular Outcomes
J.Emanuel Finet MD, Case Western Reserve University, Cleveland, Ohio.
Ajit Janardhan MD, PhD, Washington University, St.Louis, Missouri
Siva Kumar Soma MD, Allegheny General Hospital, Pittsburg, PA.
Madhu Reddy MD, University of Kansas Medical Center, Kansas City, Kansas.
Abstract Summary: The role of percutaneous left ventricular assist devices (pLVADs) for hemodynamic support during Ventricular tachycardia (VT) ablation was assessed in a multicenter study. Patients with intra aortic balloon pump (IABP group) were compared with patients with either Impella or a TandemHeart device (non-IABP group). They concluded that Impella and TandemHeart implantation for unstable VT ablation help in performing more activation mapping, ablating more unstable VT’s and requiring fewer rescue shocks during the procedure when compared to using IABP.
Stavros Stavrakis MD, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
Saurabh Malhotra MD, Krannert Institute of Cardiology, Indiana University, Indianapolis, Indiana
Luigi DiBiase MD, Texas Cardiac Arrhythmia Institute, Austin, Texas
Subba Vanga, University of Kansas Hospital, Kansas City, Kansas
Left Atrial Volume and Pulmonary Vein Orifice Area after Atrial Fibrillation Ablation
Luigi DiBiase, Texas Cardiac Arrhythmia Institute, Austin, Texas
Isolation of the Left Atrial Appendage: Techniques and Safety
Jayasaree Pillarisetti, University of Kansas Hospital, Kansas City, Kansas
Combination of Clopidogrel and Proton Pump Inhibitors in Patients Undergoing Revascularization – A Single Center Experience